Nice work. These decoys would most certainly also block OPV Type I IFN soluble receptors, in vitro at least. Hoping their clinical path toward practical use turns out to be smooth and fruitful (and cheap and fast too!).
March 27, 2025 at 6:13 AM
Nice work. These decoys would most certainly also block OPV Type I IFN soluble receptors, in vitro at least. Hoping their clinical path toward practical use turns out to be smooth and fruitful (and cheap and fast too!).
I enjoyed the podcast. Cool stuff.
February 6, 2025 at 5:17 AM
I enjoyed the podcast. Cool stuff.